Tag:

Johnson & Johnson

Tylenol Murders Suspect Found Dead In Massachusetts Apartment Tylenol Murders Suspect Found Dead In Massachusetts Apartment
Tylenol Murders Suspect Found Dead In Massachusetts Apartment The prime suspect in a crime that killed seven people was found dead in Massachusetts, officials say.  James Lewis, who claimed responsibility for the 1982 Tylenol murders, was found dead in Cambridge in an apartment on Gore Street around 4 p.m. on Sunday, July 9, according to the Cambridge Police Department.  He was declared dead shortly after first responders arrived at the scene.  An initial investigation determined that his death was not suspicious.  Lewis wrote a letter to Johnson & Johnson claiming responsibility for tampering with Tylenol products and demand…
COVID-19: 'Many Variants Are Coming,' Pfizer CEO Warns, Saying Fourth Shot Will Be Needed COVID-19: 'Many Variants Are Coming,' Pfizer CEO Warns, Saying Fourth Shot Will Be Needed
Covid-19: 'Many Variants Are Coming,' Pfizer CEO Warns, Saying Fourth Shot Will Be Needed Warning that "many variants are coming," the chairman and chief executive officer of Pfizer says a fourth dose of the COVID-19 -- a second booster shot -- will be needed. Appearing on CBS-TV's "Face the Nation" on Sunday, March 13, Dr. Albert Bourla was asked if a COVID booster shot could become recommended each fall - similar to a flu shot. "I think so," Bourla responded. "And I think this is what we are trying now to make." Bourla said Pfizer is trying "very diligently to stay ahead of the virus" because "many variants are coming and Omicron was the first one that was able to evade in a …
COVID-19: Johnson & Johnson Pauses Vaccine Production, Reports Say COVID-19: Johnson & Johnson Pauses Vaccine Production, Reports Say
Covid-19: Johnson & Johnson Pauses Vaccine Production, Reports Say The only Johnson & Johnson facility currently making viable batches of the company's one-dose COVID-19 vaccine has temporarily halted its production, according to a new report. According to The New York Times, Johnson & Johnson has stopped production of its current vaccine, potentially to create a more profitable version aimed at other viruses. With production on hold at its Dutch facility in the city of Leiden, hundreds of millions of doses could be taken out of circulation, though it is unclear how vaccine supplies in the US have been affected. Ayoade Alakija, a co-head of the A…
COVID-19: Moderna Vaccine Gets Full Approval From FDA COVID-19: Moderna Vaccine Gets Full Approval From FDA
Covid-19: Moderna Vaccine Gets Full Approval From FDA Federal officials have granted full approval to Moderna’s COVID-19 vaccine following its authorization last year for emergency use. On Monday, Jan. 31, the Food and Drug Administration (FDA) announced that Moderna’s vaccine has been granted its full approval, joining the Pfizer shot which was authorized months ago. The move comes after tens of millions of doses of the Moderna vaccine have already been administered across the country. It also represents Moderna’s first FDA-approved product in the US. Officials said the FDA reviewed months of additional follow-up data submitted by Moderna to…
COVID-19: CDC Shortens Waiting Period For Pfizer Booster Shots COVID-19: CDC Shortens Waiting Period For Pfizer Booster Shots
Covid-19: CDC Shortens Waiting Period For Pfizer Booster Shots Americans who received the Pfizer and BioNTech COVID-19 vaccine can now get a booster shot in a shorter timeframe than originally recommended, according to federal health officials who passed a pair of measures to make the vaccine more readily available. The US Centers for Disease Control and Prevention (CDC) announced on Tuesday, Jan. 4 that booster shots should be made available five months after receiving the second dose of the vaccine, down from the original recommendation of at least six months. Those who received the Moderna vaccine must still wait at least six months after their seco…
COVID-19: CDC Cuts Isolation Time In Half For Those Not Displaying Symptoms COVID-19: CDC Cuts Isolation Time In Half For Those Not Displaying Symptoms
Covid-19: CDC Cuts Isolation Time In Half For Those Not Displaying Symptoms The Centers for Disease Control and Prevention (CDC) has shortened the amount of time it recommends people isolate if they have contracted COVID-19 and are not experiencing symptoms. The CDC said in an announcement on Monday, Dec. 27, that based on what is currently known about COVID-19 and the Omicron variant, it is reducing the recommended time for isolation from 10 days to five days for those who have tested positive and are asymptomatic.  After leaving isolation, people should wear a mask for the next five days when around others, the CDC said. Health officials said those who are …
COVID-19: CDC Panel Recommends Moderna, Pfizer Vaccines Over Johnson & Johnson Jab COVID-19: CDC Panel Recommends Moderna, Pfizer Vaccines Over Johnson & Johnson Jab
Covid-19: CDC Panel Recommends Moderna, Pfizer Vaccines Over Johnson & Johnson Jab The Centers for Disease Control and Prevention (CDC) issued new guidance saying that people shouldn’t get the one-dose Johnson & Johnson COVID-19 shot if the Pfizer or Moderna option is available. Citing potentially life-threatening blood clots liked to the J & J jab, the CDC’s Advisory Committee on Immunization Practices (ACIP) met on Thursday, Dec. 16 following an update from the Food and Drug Administration. Federal officials halted the use of the Johnson & Johnson vaccine earlier this year for 10 days in April after six women experienced the blood-clotting problem — the only…
COVID-19: Pfizer Expected To Seek Approval For Boosters For All Adults COVID-19: Pfizer Expected To Seek Approval For Boosters For All Adults
Covid-19: Pfizer Expected To Seek Approval For Boosters For All Adults Pfizer and European partner BioNTech are expected to seek federal authorization to administer its COVID-19 booster shot to all Americans over the age of 18. As soon as this week, the biopharmaceutical company is reportedly planning to seek US Food and Drug Administration (FDA) approval for booster shots for anyone 18 and older. Currently, only Americans 65 and older, those who are immunocompromised and anyone whose job puts them at a larger risk for exposure are eligible for Pfizer booster shots. The FDA is considered likely to grant the request, potentially before Thanksgiving and the hol…
COVID-19: Immunocompromised People May Need Fourth Dose, CDC Says COVID-19: Immunocompromised People May Need Fourth Dose, CDC Says
Covid-19: Immunocompromised People May Need Fourth Dose, CDC Says Some Americans may require a fourth shot of the COVID-19 vaccine if they are immunocompromised, according to new federal guidance. The Centers for Disease Control and Prevention (CDC), said that adults 18 and older who received the Pfizer or Moderna COVID-19 vaccines and are moderately or severely immunocompromised may get a fourth dose at least six months after getting their third shot, the guidance states. Officials cautioned that Johnson & Johnson recipients “should not receive more than two COVID-19 vaccine doses,” though a second is recommended. The CDC authorized a thir…
COVID-19: FDA Authorizes Moderna, J&J Booster Shots For Millions Of Americans COVID-19: FDA Authorizes Moderna, J&J Booster Shots For Millions Of Americans
Covid-19: FDA Authorizes Moderna, J&J Booster Shots For Millions Of Americans The Food and Drug Administration has authorized the use of Johnson & Johnson and Moderna COVID-19 booster shots for millions of people across the United States. The FDA made the announcement on Wednesday afternoon, Oct. 20, nearly a month after the agency authorized the use of a Pfizer COVID-19 booster shot.  The agency said a single booster dose of the Moderna vaccine can be administered at least six months after the two-dose vaccine series is complete in the following groups of people: 65 years of age and older 18 through 64 years of age at high risk of severe COVID-19 18 …
COVID-19: Johnson & Johnson To Seek Authorization For Booster Shot COVID-19: Johnson & Johnson To Seek Authorization For Booster Shot
Covid-19: Johnson & Johnson To Seek Authorization For Booster Shot Johnson & Johnson is seeking federal approval for its COVID-19 booster shots, which could make it the latest to be authorized by the US Food and Drug Administration (FDA). On Monday, Oct. 4, a spokesperson for the pharmaceutical company announced that they were looking to gain approval to begin administering booster shots for its one-dose vaccine. Last month, regulators authorized a booster shot for some recipients of the Pfizer vaccine and are considering authorization this month for recipients of the Moderna vaccine. In total, according to reports, more than 15 million Am…
COVID-19: School District In Region Considering Vaccine Mandate COVID-19: School District In Region Considering Vaccine Mandate
Covid-19: School District In Region Considering Vaccine Mandate A school district in Western Massachusetts is considering a COVID-19 vaccination mandate to go along with orders to wear facial coverings while in school buildings. Officials in the Amherst-Pelham Regional School District are considering taking the extra step to provide extra protection against the spread of the virus by mandating faculty and staff members all get the COVID-19 vaccine. The decision will now move forward to a special school committee vote. Officials noted that if mandated, particular religious and health exemptions would have to be agreed upon between the school and its se…
COVID-19: CDC Reveals Which Vaccine Is More Effective In Preventing Hospitalizations COVID-19: CDC Reveals Which Vaccine Is More Effective In Preventing Hospitalizations
Covid-19: CDC Reveals Which Vaccine Is More Effective In Preventing Hospitalizations The Centers for Disease Control and Prevention (CDC) has released a new study that found which of the three US-approved COVID-19 vaccines are most effective in preventing hospitalizations, ICU visits, or potential intubation. A recently released study from the CDC determined that the Moderna vaccine was slightly more effective in preventing hospitalizations than the Pfizer or Johnson & Johnson vaccines. In total, approximately 32,000 patients that were treated in hospitals in nine US states were studied by the CDC over the summer and it was determined that the Moderna shot was most effe…
COVID-19: CDC Reveals Which Vaccine Is More Effective In Preventing Hospitalizations COVID-19: CDC Reveals Which Vaccine Is More Effective In Preventing Hospitalizations
Covid-19: CDC Reveals Which Vaccine Is More Effective In Preventing Hospitalizations The Centers for Disease Control and Prevention (CDC) has released a new study that found which of the three US-approved COVID-19 vaccines are most effective in preventing hospitalizations, ICU visits, or potential intubation. A recently released study from the CDC determined that the Moderna vaccine was slightly more effective in preventing hospitalizations than the Pfizer or Johnson & Johnson vaccines. In total, approximately 32,000 patients that were treated in hospitals in nine US states were studied by the CDC over the summer and it was determined that the Moderna shot was most effe…
COVID-19: FDA Likely To Approve Brand-New Time Frame For Booster Shot COVID-19: FDA Likely To Approve Brand-New Time Frame For Booster Shot
Covid-19: FDA Likely To Approve Brand-New Time Frame For Booster Shot The timeline for COVID-19 booster shots may be accelerated as the US Food and Drug Administration (FDA) is expected to approve booster shots for all Americans after six months, not eight, as previously announced. According to reports, as more data is examined by federal health officials, it is more likely that booster shots will be required sooner than later for the Pfizer and Moderna vaccines. Before they can go into arms, the FDA must authorize booster shots for each vaccine. A spokesperson for the agency said that under its general policy it "cannot comment on or confirm the existence" o…
COVID-19: FDA Grants Full Approval For Pfizer Vaccines, With More Mandates Now Expected COVID-19: FDA Grants Full Approval For Pfizer Vaccines, With More Mandates Now Expected
Covid-19: FDA Grants Full Approval For Pfizer Vaccines, With More Mandates Now Expected The US Food and Drug Administration (FDA) has granted full approval to the Pfizer/BioNTech COVID-19 vaccine for anyone 16 and older. On Monday, Aug. 23, the FDA announced that the Pfizer vaccine has been granted full approval, which is expected to potentially open the door for more COVID-19 vaccine mandates. The Pentagon will mandate vaccines for its 1.4 million active-duty service members, following the FDA approval Monday. United Airlines recently said its employees will be required to show proof of vaccination within five weeks of regulatory approval.  Pfizer is the first COVID-1…
COVID-19: CDC Announces Starting Date For Booster Shots COVID-19: CDC Announces Starting Date For Booster Shots
Covid-19: CDC Announces Starting Date For Booster Shots Federal health officials have set a date for when they plan to begin rolling out COVID-19 booster shots to help curtail the spread of new variants of the virus. Citing new data that showed Pfizer and Moderna vaccines’ effectiveness wanes over time, President Joe Biden’s administration announced that beginning the week of Monday, Sept. 20, booster shots would be made available for many Americans. Earlier story - COVID-19: US Expected To Announce Time Frame For All Americans To Get Booster Shots The Centers for Disease Control and Prevention (CDC) and US Food and Drug Administration (FDA) sa…
Sunscreen Recall May Be Expanded Due To Cancer-Causing Chemical Sunscreen Recall May Be Expanded Due To Cancer-Causing Chemical
Sunscreen Recall May Be Expanded Due To Cancer-Causing Chemical A team of researchers is now asking the Food and Drug Administration to recall a number of sunscreen brands after finding that they may contain a cancer-causing chemical. This follows an earlier recall of five sunscreen brands. Earlier report: Five Sunscreens Recalled Due To Cancer-Causing Chemical The New York Post reported that a team of researchers led by Executive Director of Haereticus Environmental Laboratory Craig Downs, asked the FDA to recall sunscreens containing octocrylene. They said the ingredient could degrade to suspected carcinogen benzophenone. The NY Post s…
COVID-19: FDA Aims To Give Final Approval To Pfizer Vaccine Next Month COVID-19: FDA Aims To Give Final Approval To Pfizer Vaccine Next Month
Covid-19: FDA Aims To Give Final Approval To Pfizer Vaccine Next Month The Food and Drug Administration (FDA) is expected to determine whether or not to give full approval of Pfizer’s COVID-19 vaccine as soon as next month. As the Delta variant rapidly rages through the country, causing spikes in new COVID-19 cases, the FDA is reportedly accelerating its timeline to fully approve the Pfizer vaccine, which was the first shot available. Currently, the Pfizer - as well as the Johnson & Johnson and Moderna - vaccines have been given emergency use authorization. Under the current timeline, the FDA hopes to have full approval by Labor Day (Monday, Sept. 6). It…
COVID-19: FDA Expected To Authorize Booster Shots For Immunocompromised People COVID-19: FDA Expected To Authorize Booster Shots For Immunocompromised People
Covid-19: FDA Expected To Authorize Booster Shots For Immunocompromised People The US Food and Drug Administration is expected to move forward quickly with authorization of COVID-19 booster shots for some Americans who are immunocompromised, according to reports. Health officials said that the third shot of the current two-dose Pfizer and Moderna vaccine could be authorized within the next 48 hours, though no official timetable has been set as variants of the virus and COVID-19 mutations continue to cause a surge in new cases. Before a vaccine can be used in new ways outside existing authorization it requires new approval from the FDA. Currently, the Moderna, Pfizer…
COVID-19: Unvaccinated Are More Than Twice As Likely To Get Virus A Second Time, CDC Says COVID-19: Unvaccinated Are More Than Twice As Likely To Get Virus A Second Time, CDC Says
Covid-19: Unvaccinated Are More Than Twice As Likely To Get Virus A Second Time, CDC Says A new study by the US Centers for Disease Control and Prevention (CDC) found that COVID-19 vaccines offer better and more protection against reinfection of the virus than just natural immunity among those who already have been infected. On Friday, Aug. 6, the CDC released the findings of a new study of nearly 1,000 Americans who previously tested positive for COVID-19 but remained unvaccinated. According to the study, those who were unvaccinated proved to be more than twice as likely to become infected for a second time than those who were fully vaccinated against the virus. Researchers …
COVID-19: Cape Cod Cluster Linked To Delta Variant Grows To 430 Cases COVID-19: Cape Cod Cluster Linked To Delta Variant Grows To 430 Cases
Covid-19: Cape Cod Cluster Linked To Delta Variant Grows To 430 Cases Click here for an updated story - COVID-19: Cape Cod Cluster Among Vaccinated Led To Mask Shift; CDC Says 'The War Has Changed' The highly contagious Delta variant has become a major cause of concern in a Cape Cod community following a recent breakout of new COVID-19 infections. There are now more than 430 active cases of COVID-19 in Provincetown as of Tuesday, July 27, more than triple the cases reported last week, most of which have been linked to the variant. According to the Massachusetts Department of Public Health, genetic sequencing of initial samples associated with the recent …
COVID-19: Fries With That? Hartford County McDonald's Holds Vaccine Clinic COVID-19: Fries With That? Hartford County McDonald's Holds Vaccine Clinic
Covid-19: Fries With That? Hartford County McDonald's Holds Vaccine Clinic Health officials in Connecticut are teaming with McDonald’s to host a pop-up COVID-19 vaccination clinic as the virus continues to spread across the region. The North District Health Department in Hartford County announced a pop-up clinic that will be held at the McDonald’s restaurant in Enfield as health officials monitor a rise in new cases of the virus. Officials said the clinic will provide either the Pfizer or Johnson & Johnson vaccine from 1 p.m. to 3 p.m. on Monday, July 26. "CT’s adult population is one of the most vaccinated against Covid in the country, and we can prevent t…
Five Sunscreens Recalled Due To Cancer-Causing Chemical Five Sunscreens Recalled Due To Cancer-Causing Chemical
Five Sunscreens Recalled Due To Cancer-Causing Chemical Johnson & Johnson is recalling five of its aerosol sunscreens after testing found low levels of a carcinogen in the products. On Wednesday, July 14, the company reported that low levels of benzene were found in the following products: NEUTROGENA® Beach Defense® aerosol sunscreen, NEUTROGENA® Cool Dry Sport aerosol sunscreen, NEUTROGENA® Invisible Daily™ defense aerosol sunscreen, NEUTROGENA® Ultra Sheer® aerosol sunscreen, and AVEENO® Protect + Refresh aerosol sunscreen J&J said benzene isn't an ingredient in any of the products, and it is investigating the cause.  Anyone usi…
COVID-19: FDA To Announce J&J Vaccine Has Been Linked To Rare Disorder, Report Says COVID-19: FDA To Announce J&J Vaccine Has Been Linked To Rare Disorder, Report Says
Covid-19: FDA To Announce J&J Vaccine Has Been Linked To Rare Disorder, Report Says The Food and Drug Administration is reportedly getting ready to announce a warning that the Johnson & Johnson COVID-19 vaccine has been linked to a rare autoimmune disorder. The Washington Post reported on Monday, July 12, that the Centers for Disease Control and Prevention said about 100 reports of Guillain-Barré syndrome have been detected among people who have received the Johnson & Johnson vaccine in the United States.  More than 12.8 million doses of the Johnson & Johnson vaccine have been administered in the U.S., the CDC reported. The Mayo Clinic said…
COVID-19: New US-Made Vaccine Has 90 Percent Efficiency Rate, Can Be Stored In Refrigerators COVID-19: New US-Made Vaccine Has 90 Percent Efficiency Rate, Can Be Stored In Refrigerators
Covid-19: New Us-made Vaccine Has 90 Percent Efficiency Rate, Can Be Stored In Refrigerators An American biotech company announced that it has concluded the latest phase of clinical trials for its COVID-19 vaccine, which has proven to be highly effective. Novavax announced on Monday, June 14 that its vaccine has an overall efficacy rate of 90.4 percent in a Phase 3 trial that took place across the United States and Mexico. The Novavax vaccine can be stored in standard refrigerators, making it easier to distribute. Additional analysis of the trial is ongoing, according to the company, and will be submitted to peer-reviewed journals for publication. 
The company said that the vacc…
COVID-19: CDC Releases Brand-New Data On Hospitalized, Fatal Vaccine Breakthrough Cases COVID-19: CDC Releases Brand-New Data On Hospitalized, Fatal Vaccine Breakthrough Cases
Covid-19: CDC Releases Brand-New Data On Hospitalized, Fatal Vaccine Breakthrough Cases The Centers for Disease Control & Prevention (CDC) has released brand-new data on the number of people who have been hospitalized or died despite being fully vaccinated for COVID-19.  To be fully vaccinated, two weeks or more must have passed since they received the second dose of the Pfizer or Moderna vaccine or the single-dose Johnson & Johnson vaccine. As of Monday, May 17,  more than 123 million people in the United States had been fully vaccinated.  During that time, the CDC said it received a total of 1,949 reports from 47 states and territories of vaccine brea…
COVID-19: These Retailers Are Allowing Maskless Shopping For Fully Vaccinated COVID-19: These Retailers Are Allowing Maskless Shopping For Fully Vaccinated
Covid-19: These Retailers Are Allowing Maskless Shopping For Fully Vaccinated With the Centers for Disease Control and Prevention (CDC) and most states loosening up mask-wearing restrictions, many retailers are following suit and are enacting new policies for customers and employees. The CDC said last week that fully vaccinated people do not need to wear a mask or stay 6 feet apart from others in most cases, whether indoors or outdoors. People are considered fully vaccinated two weeks after they receive the second dose of the Pfizer or Moderna vaccines or the single dose of Johnson & Johnson. The following mandates are in place at thes…
COVID-19: Details Emerge On Vaccine Brand Taken By Star Shortstop, Seven Other Infected Yankees COVID-19: Details Emerge On Vaccine Brand Taken By Star Shortstop, Seven Other Infected Yankees
Covid-19: Details Emerge On Vaccine Brand Taken By Star Shortstop, Seven Other Infected Yankees Despite being fully vaccinated for COVID-19, eight members of the New York Yankees still tested positive for the virus after receiving the one-dose Johnson & Johnson shot. The eight are: starting shortstop Gleyber Torres, third base coach Phil Nevin, first base coach Reggie Willits, pitching coach Matt Blake, and four support staffers. Related story - COVID-19: Fully Vaccinated TV Host, Star Shortstop, Seven Other NY Yankees Test Positive According to the initial clinical trial results, the single-dose Johnson & Johnson vaccine has proven to be 72 percent effective against COVID-1…
COVID-19: CDC Issues Brand-New Guidance On Mask-Wearing Indoors COVID-19: CDC Issues Brand-New Guidance On Mask-Wearing Indoors
Covid-19: CDC Issues Brand-New Guidance On Mask-Wearing Indoors The Centers for Disease Control and Prevention (CDC) is easing indoor mask-wearing guidance for Americans who are fully vaccinated for COVID-19. On Thursday afternoon, May 13, CDC Director Dr. Rochelle Walensky announced the new guidance at a White House briefing, saying that anyone who has received both shots of the Pfizer or Moderna vaccine, or the one-dose Johnson & Johnson shot can safely stop wearing masks indoors, except under some circumstances. The new guidance calls for continued mask-wearing in more crowded indoor spaces such as on mass transportation, hospitals, prisons, or …
COVID-19: Moderna Will Double Size Of Vaccine Manufacturing Space COVID-19: Moderna Will Double Size Of Vaccine Manufacturing Space
Covid-19: Moderna Will Double Size Of Vaccine Manufacturing Space With the goal of producing billions of COVID-19 vaccine doses by the end of 2022, Moderna announced that it will be expanding its production facility, located in New England. The biotechnology company, which is currently one of three companies that have been granted emergency use authorization to produce COVID-19 vaccines in the United States (along with Pfizer and Johnson & Johnson), announced that it will be doubling the size of the Moderna Technology Center in Norwood, Massachusetts. According to the company, the expansion includes an increase of the company’s production and lab spac…